Kevin Maresca

3.9k total citations
72 papers, 3.2k citations indexed

About

Kevin Maresca is a scholar working on Radiology, Nuclear Medicine and Imaging, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Kevin Maresca has authored 72 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Radiology, Nuclear Medicine and Imaging, 25 papers in Pulmonary and Respiratory Medicine and 23 papers in Oncology. Recurrent topics in Kevin Maresca's work include Radiopharmaceutical Chemistry and Applications (49 papers), Prostate Cancer Treatment and Research (13 papers) and Medical Imaging and Pathology Studies (11 papers). Kevin Maresca is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (49 papers), Prostate Cancer Treatment and Research (13 papers) and Medical Imaging and Pathology Studies (11 papers). Kevin Maresca collaborates with scholars based in United States, Canada and United Kingdom. Kevin Maresca's co-authors include John W. Babich, Jon Zubieta, John L. Joyal, John F. Valliant, Shawn Hillier, William C. Eckelman, Craig Zimmerman, F.J. Femia, Sangeeta Ray Banerjee and John Barrett and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Nature Communications.

In The Last Decade

Kevin Maresca

69 papers receiving 3.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kevin Maresca United States	30	2.0k	1.2k	1.2k	622	608	72	3.2k
Yasushi Arano Japan	31	1.9k 1.0×	695 0.6×	1.0k 0.9×	665 1.1×	217 0.4×	167	3.0k
Hans‐Jürgen Pietzsch Germany	28	1.7k 0.8×	564 0.5×	818 0.7×	406 0.7×	521 0.9×	124	2.5k
Thomas L. Mindt Switzerland	33	1.6k 0.8×	392 0.3×	952 0.8×	1.0k 1.6×	1.5k 2.5×	86	3.4k
Mark Bartholomä Germany	25	1.5k 0.7×	931 0.8×	872 0.7×	252 0.4×	207 0.3×	87	2.2k
B. Johannsen Germany	28	1.4k 0.7×	344 0.3×	685 0.6×	544 0.9×	452 0.7×	141	2.4k
Björn Wängler Germany	36	2.0k 1.0×	403 0.3×	1.3k 1.1×	946 1.5×	569 0.9×	155	3.9k
Lurdes Gano Portugal	27	896 0.4×	329 0.3×	720 0.6×	416 0.7×	502 0.8×	131	2.1k
Sajinder K. Luthra United Kingdom	34	1.8k 0.9×	373 0.3×	397 0.3×	908 1.5×	563 0.9×	103	3.5k
F.J. Femia United States	20	860 0.4×	425 0.4×	511 0.4×	246 0.4×	282 0.5×	35	1.4k
Isabel Santos Portugal	39	2.1k 1.0×	522 0.4×	2.0k 1.7×	837 1.3×	2.0k 3.2×	223	4.8k

Countries citing papers authored by Kevin Maresca

Since Specialization

Citations

This map shows the geographic impact of Kevin Maresca's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kevin Maresca with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kevin Maresca more than expected).

Fields of papers citing papers by Kevin Maresca

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kevin Maresca. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kevin Maresca. The network helps show where Kevin Maresca may publish in the future.

Co-authorship network of co-authors of Kevin Maresca

This figure shows the co-authorship network connecting the top 25 collaborators of Kevin Maresca. A scholar is included among the top collaborators of Kevin Maresca based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kevin Maresca. Kevin Maresca is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Weberling, Lukas D., Andreas Ochs, Mitchel Benovoy, et al.. (2025). Machine Learning to Automatically Differentiate Hypertrophic Cardiomyopathy, Cardiac Light Chain, and Cardiac Transthyretin Amyloidosis: A Multicenter CMR Study. Circulation Cardiovascular Imaging. 18(7). e017761–e017761. 2 indexed citations

Colburg, Deana R.C., Ophir Vermesh, Anthony Chen, et al.. (2025). Advancing In Vivo Detection of T-Cell Function: Development and Preclinical Evaluation of ⁸⁹Zr-Ivuxolimab, a Human OX40 PET Tracer. Journal of Nuclear Medicine. 66(9). 1449–1457.

Sako, Chiharu, Chong Duan, Kevin Maresca, et al.. (2024). Real-world and clinical trial validation of a deep learning radiomic biomarker for PD-(L)1 immune checkpoint inhibitor response in stage IV NSCLC.. Journal of Clinical Oncology. 42(16_suppl). 102–102.

Zeller, Matthias, Cuihua Wang, Edmund J. Keliher, et al.. (2023). Myeloperoxidase PET Imaging Tracks Intracellular and Extracellular Treatment Changes in Experimental Myocardial Infarction. International Journal of Molecular Sciences. 24(6). 5704–5704. 2 indexed citations

Flach, Rachel J. Roth, Chunyan Su, Christian Cortés‐Campos, et al.. (2019). Myeloperoxidase inhibition in mice alters atherosclerotic lesion composition. PLoS ONE. 14(3). e0214150–e0214150. 35 indexed citations

Collier, Thomas, Marc D. Normandin, Nickeisha A. Stephenson, et al.. (2017). Synthesis and preliminary PET imaging of 11C and 18F isotopologues of the ROS1/ALK inhibitor lorlatinib. Nature Communications. 8(1). 15761–15761. 49 indexed citations

Chin, Bennett B., James F. Kronauge, F.J. Femia, et al.. (2014). Phase-1 Clinical Trial Results of High-Specific-Activity Carrier-Free ¹²³I-Iobenguane. Journal of Nuclear Medicine. 55(5). 765–771. 18 indexed citations

Hillier, Shawn, Kevin Maresca, Genliang Lu, et al.. (2013). ^99mTc-Labeled Small-Molecule Inhibitors of Prostate-Specific Membrane Antigen for Molecular Imaging of Prostate Cancer. Journal of Nuclear Medicine. 54(8). 1369–1376. 183 indexed citations

Barrett, John, John L. Joyal, Shawn Hillier, et al.. (2010). Comparison of High-Specific-Activity Ultratrace ^123/131 I-MIBG and Carrier-Added ^123/131 I-MIBG on Efficacy, Pharmacokinetics, and Tissue Distribution. Cancer Biotherapy and Radiopharmaceuticals. 25(3). 299–308. 55 indexed citations

10.

Albaugh, Vance L., Thomas C. Vary, Olga Ilkayeva, et al.. (2010). Atypical Antipsychotics Rapidly and Inappropriately Switch Peripheral Fuel Utilization to Lipids, Impairing Metabolic Flexibility in Rodents. Schizophrenia Bulletin. 38(1). 153–166. 67 indexed citations

11.

Albaugh, Vance L., Pengxiang She, Charles H. Lang, et al.. (2010). Olanzapine promotes fat accumulation in male rats by decreasing physical activity, repartitioning energy and increasing adipose tissue lipogenesis while impairing lipolysis. Molecular Psychiatry. 16(5). 569–581. 91 indexed citations

12.

Bartholomä, Mark, John F. Valliant, Kevin Maresca, John W. Babich, & Jon Zubieta. (2008). Single amino acid chelates (SAAC): a strategy for the design of technetium and rhenium radiopharmaceuticals. Chemical Communications. 493–512. 163 indexed citations

13.

Femia, F.J., Kevin Maresca, Shawn Hillier, et al.. (2008). Synthesis and Evaluation of a Series of ^99mTc(CO)₃⁺ Lisinopril Complexes for In Vivo Imaging of Angiotensin-Converting Enzyme Expression. Journal of Nuclear Medicine. 49(6). 970–977. 25 indexed citations

14.

Maresca, Kevin, Shawn Hillier, F.J. Femia, et al.. (2008). A Series of Halogenated Heterodimeric Inhibitors of Prostate Specific Membrane Antigen (PSMA) as Radiolabeled Probes for Targeting Prostate Cancer. Journal of Medicinal Chemistry. 52(2). 347–357. 240 indexed citations

15.

Stephenson, Karin A., Sangeeta Ray Banerjee, Travis R. Besanger, et al.. (2004). Bridging the Gap between in Vitro and in Vivo Imaging: Isostructural Re and ^99m Tc Complexes for Correlating Fluorescence and Radioimaging Studies. Journal of the American Chemical Society. 126(28). 8598–8599. 167 indexed citations

16.

Femia, F.J., Xiaohong Chen, Kevin Maresca, John W. Babich, & Jon Zubieta. (2000). Synthesis and crystal and molecular structure of a tetranuclear cluster based on the rhenium(III)-bisorganohydrazino core: [Re(HNNC4H3N2)(NNC4H3N2)(OCH3)2]4. Inorganica Chimica Acta. 307(1-2). 160–163. 7 indexed citations

17.

Femia, F.J., Xiaohong Chen, Kevin Maresca, John W. Babich, & Jon Zubieta. (2000). Syntheses and structural characterization of rhenium-bis-hydrazinopyrimidine core complexes with thiolate and Schiff base coligands. Inorganica Chimica Acta. 310(2). 210–216. 9 indexed citations

18.

Femia, F.J., Xiaoyuan Chen, Kevin Maresca, et al.. (2000). Synthesis and characterization of complexes of the {ReO}3+ core with SNS and S donor ligands. Inorganica Chimica Acta. 306(1). 30–37. 19 indexed citations

19.

Pérez‐Lourido, P., Jaime Romero, J.A. García-Vázquez, et al.. (1999). Synthesis and Characterization of Indium Compounds with Phosphinothiol Ligands. The Crystal and Molecular Structures of [In{2-(Ph₂P)C₆H₄S}₃], [In{2-(Ph₂P)-6-(Me₃Si)C₆H₃S}₂{2-(Ph₂PO)-6-(Me₃Si)C₆H₃S}], and [NMe₄][In{PhP(C₆H₄S-2)₂}₂]·CH₃CN. Inorganic Chemistry. 38(6). 1293–1298. 16 indexed citations

20.

Pérez‐Lourido, P., Jaime Romero, J.A. García-Vázquez, et al.. (1999). Synthesis and Characterization of Zinc and Cadmium Compounds with Arenephosphinothiol Ligands. Crystal and Molecular Structures of [Cd₂{2-(Ph₂PO)C₆H₄S}₄], [Zn{2-(Ph₂P)-6-(Me₃Si)C₆H₃S}₂], [Cd{2-(Ph₂PO)-6-(Me₃Si)C₆H₃S}₂(CH₃OH)], and [Zn{PhPO(C₆H₄S-2)₂}(bipy)]. Inorganic Chemistry. 38(16). 3709–3715. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact